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Background-—The natural history and long-term outcome in pediatric patients with idiopathic ventricular ﬁbrillation (IVF) are poorly
characterized. We sought to deﬁne the clinical characteristics and long-term outcomes of a pediatric cohort with an initial
diagnosis of IVF.
Methods and Results-—Patients were included from an International Registry of IVF (consisting of 496 patients). Inclusion criteria
were: (1) VF with no identiﬁable cause following comprehensive analysis for ischemic, electrical or structural heart disease and (2)
age ≤16 years. These included 54 pediatric IVF cases (age 12.73.7 years, 59% male) among whom 28 (52%) had a previous
history of syncope (median 2 syncopal episodes [interquartile range 1]). Thirty-six (67%) had VF in situations associated with high
adrenergic tone. During a median 10912 months of follow-up, 31 patients (57%) had recurrence of ventricular arrhythmias,
mainly VF. Two patients developed phenotypic expression of an inherited arrhythmia syndrome during follow-up (hypertrophic
cardiomyopathy and long QT syndrome, respectively). A total of 15 patients had positive genetic testing for inherited arrhythmia
syndromes. Ten patients (18%) experienced device-related complications. Three patients (6%) died, 2 due to VF storm.
Conclusions-—In pediatric patients with IVF, a minority develop a deﬁnite clinical phenotype during long-term follow-up. Recurrent
VF is common in this patient group. ( J Am Heart Assoc. 2019;8:e011172. DOI: 10.1161/JAHA.118.011172.)
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T he majority of cases of arrhythmic sudden cardiac death(SCD) in young patients are attributable to either
inherited structural cardiac diseases or primary arrhythmic
syndromes.1 In a subset of patients the cause of ventricular
ﬁbrillation remains undeﬁned despite comprehensive diag-
nostic evaluation and is referred to as idiopathic ventricular
ﬁbrillation (VF). According to contemporary guidelines idio-
pathic VF is deﬁned as resuscitated cardiac arrest that occurs
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in the absence of cardiac, metabolic, toxicological, and
respiratory causes.2 Overall, idiopathic VF accounts for up
to 8% of arrhythmic sudden cardiac death cases.3
There is a relative paucity of data on the natural history and
long-term outcome in patients of pediatric age who present
with idiopathic VF (IVF). Available studies have largely focused
on adult cohorts with IVF.4 The aim of the present study is to
deﬁne the long-term outcome in pediatric VF patients.
Methods
Data Collection
Patients were included from an International Registry of
Idiopathic Ventricular Fibrillation (IVF) that consists of 496 IVF
patients5 from 45 tertiary cardiac centers worldwide (col-
lected between March 2004 and December 2015). The data
are available on request from the authors. Criteria for
inclusion in the registry were (1) sudden cardiac arrest with
documented VF as the cause of arrest, (2) an absence of an
underlying cause following comprehensive analysis for
ischemic, electrical, infectious, or structural heart disease,
and (3) age ≤16 years. The diagnostic criteria for IVF were
based on the latest consensus guidelines.1
Patients were systematically assessed at the referring
centers after the index VF episode (before being assigned a
diagnosis of IVF). Data on past clinical symptoms, including
previous syncopal episodes, were collected. Family history of
SCD was deﬁned as a sudden death that occurred before
55 years of age in the absence of any known underlying
pathological conditions.
The clinical workup consisted of a baseline ECG, blood
tests (including cardiac enzymes and electrolytes), toxicology
screening, and cardiac imaging (echocardiography and/or
cardiac magnetic resonance imaging). Ajmaline testing was
performed in order to exclude a diagnosis of concealed
Brugada syndrome. Isoproterenol or epinephrine testing and
exercise stress testing (using a modiﬁed Bruce protocol
adapted for pediatric patients) were performed to exclude
long-QT syndrome and catecholaminergic polymorphic ven-
tricular tachycardia (VT). The aforementioned tests were
performed at the investigating physician’s discretion at the
referring center. Signal-averaged ECG and endomyocardial
biopsies were also performed at the investigating physician’s
discretion. Time of implanted cardioverter/deﬁbrillator (ICD)
implantation and device programming were left to the
decision of the referring physician (according to latest
guidelines in order to reduce the possibility of inappropriate
ICD shocks). The study was approved by the Institutional
Review Board at CHU Bordeaux (inclusion in the IVF registry
was approved by the institutional review boards at the
respective institutions).
IVF Characteristics
The circumstances during the index VF event were catego-
rized as (1) at rest, (2) daily activity, (3) sleep, (4) emotional
stress, or (5) sport/strenuous activity. “At rest” was deﬁned
as SCD that occurred during no physical activity. “Daily
activity” was deﬁned as SCD that occurred during routine
activities with very light physical activity. “Sleep” was deﬁned
as SCD occurring during bedtime or while asleep. Emotional
stress was deﬁned as intense emotion. Strenuous activity was
deﬁned as moderate to severe exercise (including in the
setting of sport).
ECG Analysis
All ECGs (during the index hospitalization and at follow-up)
were reviewed by 2 independent electrophysiologists (K.T.,
V.K.). In case of disagreement, the ECG was reviewed by a
third electrophysiologist (N.D.). ECGs were analyzed at a
paper speed of 25 mm/s and an amplitude of 10 mm/mV.
Digital calipers were used to perform measurements (EP
Calipers version 1.8 [http://www.epstudiossoftware.com/],
EP Studios, 2017). P-wave duration and dispersion were
calculated from the standard ECG during sinus rhythm where
dispersion was deﬁned as the difference between the
minimum and maximum P-wave duration. Early repolarization
was deﬁned according to the latest consensus guidelines.6
Clinical Perspective
What Is New?
• This is the ﬁrst study to systematically evaluate long-term
outcomes among pediatric patients with an initial diagnosis
of idiopathic ventricular ﬁbrillation.
• We demonstrate that among pediatric idiopathic ventricular
ﬁbrillation patients, arrhythmias commonly occur in the
context of high adrenergic tone, and there is a high
incidence of recurrent arrhythmic events.
• Only a small minority of patients develop evidence of an
underlying cardiac phenotype during long-term follow-up.
What Are the Clinical Implications?
• Over the years, the risk of recurrent arrhythmic events
continues to be elevated, and therefore, in addition to
implantation of cardiac deﬁbrillators, these patients should
be followed up closely.
• The incidence of complications related to implanted
cardioverter/deﬁbrillators in this pediatric population is
relatively high, which may have important implications in
terms of choice of device.
DOI: 10.1161/JAHA.118.011172 Journal of the American Heart Association 2
Long-Term Follow-Up of IVF in Children Frontera et al
O
R
IG
IN
A
L
R
E
S
E
A
R
C
H
D
ow
nloaded from
 http://ahajournals.org by on May 8, 2019
Abnormal QRS fragmentation was deﬁned as either ≥4 spikes
in 1 lead or >1 notches in the nadir of the R or S wave in 2
consecutive leads. Davignon criteria7 were used to exclude
right and left ventricular hypertrophy. S waves were charac-
terized in terms of amplitude and duration in lead I. T peak–T
end interval was measured from the peak to the end of the T
wave in the precordial leads.
Invasive Electrophysiology Study
Programmed ventricular stimulation was performed at the
investigating physicians’ discretion. A consistent stimulation
protocol from the right ventricular apex and outﬂow tract was
used (2 drive cycle lengths [600 and 400 ms] and 3
extrastimuli with a minimal coupling up to 180 ms [unless
ventricular arrhythmia was induced or the ventricular effective
refractory period was reached]). A sustained VT/VF episode,
deﬁned as an episode lasting >30 s or VT/VF requiring direct
current cardioversion, was considered a positive electrophys-
iological study. Nonsustained episodes (<30 s) were classi-
ﬁed as negative electrophysiological study.
Genetic Testing
When available, genetic testing for variants implicated in
heritable cardiomyopathies and/or channelopathies (long QT
syndrome, short QT syndrome, Brugada syndrome, and
catecholaminergic polymorphic ventricular tachycardia) was
performed per consensus guidelines. When a putative muta-
tion was identiﬁed, cascade screening was performed in
family members.2 The choice of genes targeted during genetic
analysis was at the treating physician’s discretion. Assign-
ment of pathogenicity of identiﬁed variants was based on
conventional guidelines.3 Repeat genetic testing with more
extensive genetic panels was performed at the treating
physician’s discretion.
Follow-Up
Patients were followed up with sequential ICD interrogations
(at least every 4 months), ECG, and cardiac imaging (echocar-
diography). Appropriate and inappropriate therapies with an
implantable deﬁbrillator were documented. Genotype and
phenotype reevaluations during follow-up were performed at
the investigating physician’s discretion. Phenotypic reevalua-
tion included repeat cardiac imaging, exercise stress testing,
and pharmacological stress testing.
Statistical Analyses
Continuous variables were expressed as meanstandard
deviation. Categorical variables were expressed as percent-
ages. Qualitative variables were compared using the Fisher
exact test, whereas the Mann-Whitney test was used for
continuous variables. Kaplan-Meier analysis was also per-
formed for arrhythmia-free survival. A P<0.05 was considered
to be statistically signiﬁcant.
Results
Patient Characteristics
Fifty-four of the 496 patients in the IVF registry fulﬁlled
inclusion criteria. Patient characteristics are summarized in
Table 1. Population Study
Age, y 12.73.7
Male, n (%) 32 (59%)
Ethnicity, n (%)
White 45 (84%)
Afro-Caribbean 5 (9%)
Asian 4 (7%)
Circumstances of SCD, n (%)
Sport/strenuous activity 15 (28%)
Daily activity 11 (20%)
Emotional stress 11 (20%)
Rest 12 (22%)
Sleep 5 (10%)
Confirmation of IVF, n (%)
Coronary angiogram 24 (44%)
Imaging
Echo 54 (100%)
CMR 38 (70%)
Treadmill test 45 (83%)
Pharmacological tests, n (%)
Isoproterenol 38 (70%)
Ajmaline 24 (44%)
Flecainide 13 (24%)
Endomyocardial biopsy 7 (13%)
Before the SCD event, n (%)
Syncope 28 (52%)
Epilepsy 5 (9%)
Palpitations 2 (4%)
Family history of SCD, n (%) 15 (28%)
First degree 10 (67%)
Second degree 3 (20%)
Third degree 2 (13%)
CMR indicates cardiac magnetic resonance; Echo, echocardiogram; IVF, idiopathic
ventricular ﬁbrillation; SCD, sudden cardiac death.
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Table 1. At the time of the index VF episode, the mean age
was 12.73.7 years. Thirty-two patients (59%) were male.
Patients were predominantly of white descent (45 white
[84%]; 5 Afro-Caribbean [9%]; 4 Asian [7%]). Twenty-eight
patients (52%) had a prior history of syncope (median 2
syncopal episodes, interquartile range 1). Twenty-four (85%)
had effort-induced syncope. The syncopal events occurred
5410 days before the sudden cardiac arrest. Five patients
(9%) had previously been diagnosed with epilepsy. None of the
patients had a history of recreational drug use. Speciﬁc
details of the circumstances of the index episode are included
in Table 1. All 54 patients underwent ICD implantation.
Fifteen patients (28%) had a family history of SCD (10
[67%] a ﬁrst-degree relative; 3 [20%] a second-degree relative;
2 [13%] a third-degree relative). The mean age of sudden
cardiac death in the relatives was 35.9 years (SD 19.7). In 1
case, sudden death occurred in 2 siblings.
Investigations
Imaging and Biopsy
Transthoracic echocardiography demonstrated a structurally
normal heart in all patients (ejection fraction 61.56.2%).
Cardiac magnetic resonance imaging was performed in 38
patients (70%) and conﬁrmed the absence of structural heart
disease. Coronary angiography was performed in 24 patients
(44%) with no cases of anomalous coronary anatomy or
signiﬁcant stenosis identiﬁed. Seven patients (13%) under-
went endomyocardial biopsy with negative results in all
cases.
Exercise and Pharmacological Testing
Forty-ﬁve patients (83%) underwent exercise stress testing,
and 38 patients (70%) had an isoproterenol challenge. There
were no QT interval abnormalities or sustained arrhythmias
during these tests. In 1 patient the isoproterenol test induced
multifocal ventricular ectopic beats. Ajmaline/ﬂecainide
challenge was performed in 37 patients (69%) and excluded
Brugada syndrome.
ECG
None of the patients presented with left or right ventricular
hypertrophy (based on the Davignon criteria). The early
repolarization pattern was present in 31 patients (57.4%).
Electrocardiographic characteristics are summarized in
Table 2. The characteristics of the subset of patients with
an early repolarization pattern are included in Table 3.
Invasive Electrophysiology Studies
An electrophysiological study was performed in 34 patients
(63%). VF was induced in 3 patients (9%). There were no cases
of inducible VT. Three patients (9%) had inducible atrial
tachycardia.
Genetic Analysis
Forty-ﬁve patients (83%) underwent genetic testing. A putative
pathogenic mutation was identiﬁed in 15 of the 45 (33%)
patients (RYR2 [n=7]; TRDN [n=2]; CALM1 [n=1]; CASQ2
Table 2. Electrocardiographic Characteristics
Characteristics Mean Value (SD)
Heart rate, bpm 76.3 (21.2)
P wave duration, ms 96.9 (17.2)
P wave dispersion, ms 36.8 (17.6)
P wave amplitude, mV 0.63 (3.66)
PR duration, ms 159.4 (30.98)
QRS duration, ms 82.9 (14.7)
IVS (Cornell), mm 1.26 (0.79)
QTc (Bazett), ms 416 (48.8)
S wave duration (I), ms 30.3 (12.2)
S wave amplitude (I), mV 0.23 (0.18)
T peak–T end, ms 88.4 (22.2)
QRS fragmentation, N (%) 25 (46.3%)
U wave, N (%) 27 (50%)
IVS indicates interventricular septum thickness (in mm); U wave, evidence of U wave on
the 12-lead ECG.
Table 3. ECG Characteristics of Subset of Patients With Early
Repolarization
No ER (n=23) ER (n=31) P Value
Female sex, N (%) 9 (40.9%) 11 (35.5%) 0.63
Age, y 12.2 13.1 0.77
HR (bpm) mean 79 74.4 0.45
P wave duration, ms 97.8 96.6 0.78
P wave amplitude, mV 0.16 0.99 0.11
P wave dispersion, ms 38.4 36.06 0.58
PR, ms 152.5 164.6 0.18
QRS duration, ms 83.6 81.7 0.60
QRS fragmentation, n (%) 10 (45.5) 14 (45.2) 0.92
IVS, mm 10.9 13.7 0.22
QTc, ms 426.5 408.8 0.19
S wave duration, ms 26 17 0.82
S wave amplitude, mV 0.156 0.162 0.21
U wave, N (%) 12 (54.5) 15 (50) 0.66
T Peak–T end, ms 94.1 84.5 0.12
ER indicates early repolarization; IVS, interventricular septum thickness (in mm).
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[n=1]; SCN5A [n=1]; KCNH2 [n=1]; MYH7 [n=1]; SLC22A5
[n=1]). Two patients did not provide consent for disclosure of
their genetic results. Based on the rapidly emerging data on
genetic variation in normal populations, we reevaluated the
prevalence of the reported genetic variants in the gnomAD
database, which spans 123 000 exomes (http://gnomad.b
roadinstitute.org/). All variants were conﬁrmed to be unique
(Table 4).
Pharmacotherapy
Twenty patients (37%) were discharged following the index VF
with no drug therapy. Eighteen (33%) were commenced on a
selective b-blocker. One patient was discharged with quini-
dine.
Outcomes
Arrhythmia Recurrences
Patients were followed up for a median time of
10912 months after the index VF episode. Thirty-one
patients (57%), experienced a recurrence of ventricular
arrhythmias (23 [74%] had only VF; 8 [26%] had only
sustained VT). Four patients (13%) experienced both VT and
VF episodes. The patients with recurrences experienced a
median of 2 appropriate shocks (interquartile range 5.5). The
ﬁrst recurrence of ventricular arrhythmia occurred after a
mean of 6.4 years after the index VF episode (Kaplan-Meier
curve, Figure 1).
In 12 of 31 patients (39%), recurrences of ventricular
arrhythmia occurred in the context of high adrenergic tone
(exercise or intense stress/emotion), and the remaining
recurrences occurred at rest. The arrhythmia recurrences
according to clinical characteristics and speciﬁc genotypes
are represented in Tables S1 and S2. One patient developed
paroxysmal atrial ﬁbrillation. The characteristics of individu-
als with VT/VF-related ICD shocks are included in Table 5.
Nine (33%) patients with VF recurrences were drug-naive.
Among the 36 patients in whom the index VF episode
occurred in the context of high adrenergic tone, 15 (42%)
had recurrent ventricular arrhythmias. In the remaining 18
patients (nonadrenergic group), 12 (67%) experienced a
recurrence of VF. Recurrence of arrhythmia occurred in 4
patients treated with selective b-blockers and in 1 patient
treated with mexiletine. Three patients (6%) died during
follow-up. Two died due to an arrhythmic storm. One patient
remained in a neurovegetative state following the arrest until
death.
Device-Related Complications
Ten patients (18%) experienced device-related complications
(ventricular lead fracture [n=5]; lead insulation defect [n=1];
further device procedures due to lead recall [n=2]; late lead
dislodgement [n=1]; device infection [n=1]). Eleven patients
(20%) experienced inappropriate shocks (sinus tachycardia
[n=1]; atrial arrhythmias [n=3]; noise on the ventricular
channel [n=3], lead fracture [n=3]; sensing lead insulation
defect [n=1]). The mean time from implant to complication
was 4114 months; the mean number of inappropriate
shocks was 1.91 (Table 6).
Table 4. Pathogenic Mutation Identiﬁed in 15 of 45 Patients
Patient Gene Identiﬁed Variant
Homozygote/
Heterozygote
MAF in
gnomAD
1 RYR2 R4608Q Heterozygote 0
5 SLC22A5 R471H Heterozygote 0
6 CASQ2 Deletion of Exon1 Heterozygote 0
17 KCNH2 A429P Heterozygote 0
18 RYR2 D4112N Heterozygote 0
19 RYR2 D4112N Heterozygote 0
22 RYR2 R4497C Heterozygote 0
29 SCN5A R1644H Heterozygote 0
37 MYH7 F48L Heterozygote 0
46 CALM N98S Heterozygote 0
47 TRDN c/53_56delACAG
p.(Asp18AlafsTer14)
Compound
heterozygote
0
48 TRDN c.502G>T
p.(Glu168Ter)
Compound
heterozygote
0
49 RYR2 c.7273T>C Heterozygote 0
50 RYR2 G3930R Heterozygote 0
51 RYR2 c.11648A>G Heterozygote 0
MAF indicates minor allele frequency.
Figure 1. Kaplan–Meier curve demonstrating freedom from
ventricular arrhythmias.
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Repeat Testing
Patients underwent systematic phenotype reevaluation
7811 months after the index VF episode: all patients
underwent repeat ECGs and transthoracic echocardiography.
Forty-ﬁve percent had a repeat cardiac magnetic resonance;
90% had a repeat stress test (with adult exercise testing
protocols); 62% had a repeat isoproterenol challenge. Repeat
genetic sequencing with an extended genetic panel was
performed in 54% of the population at the discretion of the
treating physician. One patient (2%) developed phenotypic
evidence of hypertrophic cardiomyopathy during follow-up. Of
note, that patient had previously been identiﬁed as a MYH7
variant carrier (patient 37, Table 4). None of the patients who
underwent repeat exercise stress testing or isoproterenol
challenge had exercise-induced arrhythmias. Repeat genetic
testing did not reveal additional variants. None of the long QT
gene carriers had a prolonged QT interval at the time of the
index event; 1 of the patients (patient 29 in Table 4) had
evidence of QT prolongation during follow-up (SCN5A muta-
tion carrier; QT interval 495 ms). The results of phenotypic
reevaluation are included in Figure 2.
Discussion
The main ﬁndings of the present study are as follows: (1) the
majority of SCD events in pediatric IVF patients occur in the
context of high adrenergic tone; (2) close to a ﬁfth of pediatric
IVF patients have variants in genes implicated in cate-
cholaminergic polymorphic ventricular tachycardia; (3) pedi-
atric IVF patients have a high risk of recurrent arrhythmic
events during long-term follow-up; (4) only a small minority of
patients develop evidence of an underlying cardiac phenotype
during long-term follow-up. (5) The incidence of ICD-related
complications in this pediatric population is relatively high.
The majority of reports on IVF to date have focused on adult
populations. There is a relative paucity of data on IVF in pediatric
populations. In a large cohort of adult IVF patients, Visser and
colleagues reported that, during long-term follow-up, a speciﬁc
diagnosis was identiﬁed in up to a ﬁfth of patients4 of whom
almost 50% were found to have an underlying cardiomyopathy.
In contrast to these ﬁndings, during a similar follow-up period
speciﬁc diagnoses were identiﬁed in only 4% of our pediatric
cohort. It is important to emphasize, however, that because our
cohort was of pediatric age at the index VF event, the initial
evaluation was less comprehensive than that routinely per-
formed in adult cohorts. Further, although reevaluation of our
cohort during follow-up did not reveal a speciﬁc underlying
diagnosis, the strategies for reevaluation were variable. Our
ﬁndings may, however, suggest that the underlying arrhythmo-
genic substrate in pediatric patients is distinct from that of adult
IVF patients and may have a low diagnostic yield.
A potential pathogenic genetic variant was identiﬁed in a
third of the patients in our cohort. In turn, variants in RYR2
Table 6. ICD Characteristics and Complications Encountered
During the Follow-Up
ICD characteristics
Endocardial implant, n (%) 47 (87%)
Single-chamber ICD 45 (96%)
Dual-chamber ICD 2 (4%)
Epicardial implant 4 (7%)
Subcutaneous ICD 3 (6%)
ICD complications
Inappropriate shocks, n (%) 11 (20%)
Sinus tachycardia 1 (9%)
Atrial arrhythmias 3 (27%)
Lead fracture 3 (27%)
Noise on the V channel 3 (27%)
Lead insulation defect 1 (9%)
Device-related complications, n (%) 10 (18%)
Lead fracture 5 (50%)
Lead recall 2 (20%)
Pocket infection 1 (10%)
Sensing lead insulation defect 1 (10%)
Lead dislodgement 1 (10%)
ICD indicates implanted cardioverter/deﬁbrillator.
Table 5. Recurrences of Ventricular Arrhythmias
Sex Past Syncope Family History EP Study Genetic Death
VF group (n=23) 16 male 12/23 (52%) 8/23 (35%) Performed in 3/12
Inducible (13%)
18/23 (78%)
1 CALM+
2 Triadin +
4 RyR2+
2 (9%)
VT group (n=8) 6 male 5/8 (62.5%) 5/8 (62%) Performed in 6/8 (75%)
No inducible ventricular
tachycardia
Performed in 7/8 (88%)
RyR2+ (2) and Triadin+ (2)
1 (14%)
EP indicates electrophysiological; VF, ventricular ﬁbrillation; VT, ventricular tachycardia.
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were identiﬁed in close to half of the genotype-positive
patients. Consistent with our ﬁnding, Lahrouchi et al8
reported that in patients with sudden arrhythmic death
syndrome, RYR2 variants were the most commonly identiﬁed
pathogenic/likely pathogenic variants following postmortem
genetic testing (43% of genotype-positive cases). In the study
by Visser and colleagues,4 on the other hand, the overall yield
for genetic testing was lower at 15%, with only a quarter of
genotype-positive patients harboring catecholaminergic poly-
morphic ventricular tachycardia gene variants. Of note,
patients included in our study (as in that of Lahrouchi et al)
were signiﬁcantly younger than the patients included by
Visser et al. It is important to note, however, that a signiﬁcant
proportion of apparently pathogenic RYR2 variants may not be
disease causing.9 Furthermore, although the yield of genetic
test may increase with broad multiphenotype genetic testing,
this approach may be associated with a higher incidence of
variants of uncertain signiﬁcance.10
Further, in the study of Visser and colleagues,4 a third of
adult IVF patients experienced recurrent arrhythmic events.
We observed a higher frequency of recurrent arrhythmic
events in our pediatric IVF cohort, with close to half of cases
experiencing recurrences. Importantly, despite an overall
higher arrhythmic burden, the recurrent arrhythmic events in
our cohort occurred at a later stage as compared with those
reported in the adult population. These ﬁndings suggest that,
in pediatric IVF patients, the disease process is associated
with a more malignant course, with ongoing arrhythmic risk
extending over a more prolonged period of time.
The choice of ICD device is an important consideration in
pediatric populations. In recent years increasing evidence has
emerged supporting the use of subcutaneous ICD as an
alternative to transvenous systems.11 Close to a ﬁfth of
patients in our cohort experienced device-related complica-
tions, which predominantly consisted of lead-related issues.
These ﬁndings may support the use of subcutaneous ICD in
pediatric populations.
In addition to a family history of SCD, ECG features such as
Tpeak-Tend >100 ms with U waves and right bundle branch
block were associated with more arrhythmia recurrences in
Figure 2. Summary of phenotypic evaluation following index episode and at follow-up (7811 months).
CMR indicates cardiac magnetic resonance; ECHO, echocardiogram; HCM, hypertrophic cardiomyopathy;
IVF, idiopathic ventricular ﬁbrillation; VF, ventricular ﬁbrillation.
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our cohort. Our ﬁndings are in line with similar results in the
adult population,12 and these ECG markers could potentially
modulate arrhythmic risk stratiﬁcation. However, based on
the limited size of our cohort, these results should be
interpreted with caution.
Limitations
Patients were recruited from a large number of centers over a
prolonged period of time (more than a decade) in multiple
countries. Therefore, the workup of patients following the VF
episode and ICD programming was not standardized. It must be
emphasized that guidelines for evaluation of these patients
evolved over the time period of the study; therefore, there was
some variation in the investigation of patients following
episodes of aborted sudden death. During follow-up, close to
half of the population did not undergo comprehensive genetic
testing. Medications were prescribed at the physician’s discre-
tion, and we acknowledge that is also a potential confounding
factor. Among patients who did not have a cardiac magnetic
image performed (30%), we acknowledge that a diagnosis of
myocarditis could have been missed. Genetic testing was
performed in the absence of a clear phenotype and on a
discretionary basis. Where performed, genetic testing involved
a candidate-gene approach that targeted the common genes
implicated in cardiac channelopathies and cardiomyopathies.
Conclusion
Our ﬁndings suggest that both the clinical course and
underlying arrhythmogenic substrate in pediatric patients
with IVF are distinct from those previously reported for adult
IVF cohorts.
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Table S1. Characteristics of Patients with RyR2 and Triadic mutations.  
 Gene Mutation Age at 
VF 
Family 
history 
SCD 
Adrenergic 
related index 
VF episode? 
Previous 
Syncope? 
ETT Findings Isoprenaline 
challenge 
positive? 
U waves 
1 RYR2 R4608Q 7 n y n Normal n n 
18 RYR2 D4112N 12 y n y Normal n y 
19 RYR2 D4112N  7 n y y Normal n n 
49 RYR2 c.7273T>C 14 n y n Normal n n 
50 RYR2 G3930R 14 n y y Normal n y 
51 RYR2 c.11648A>G 13 n y n Normal n y 
22 RYR2 R4497C 11 Y y y Normal n y 
47 TRDN c/53_56delACAG 
p.(Asp18AlafsTer14) 
2 n n n Normal n n 
48 TRDN c.502G>T 
p.(Glu168Ter) 
1,5 n y n Normal  n n 
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Table S2. Clinical characteristics of genotype-positive patients. 
 
 CALM1 TRDN MYH7 SCN5A KCNH2 SCL22A CASQ2 RyR2 
N (%) 1 2 1 1 1 1 1 7 
 
Circumstances of 
SCD 
 
Rest 
 
Moderate effort 
(1) 
Rest (1) 
 
Emotion 
 
Rest (1)  
 
Sport 
 
     Asleep (1) 
 
     Asleep (1) 
Moderate effort 
(3) 
Sport (2) 
School (1) 
Rest (1) 
Phenotype Negative Negative Developed HCM 1 (Long QT) Negative Negative Negative Negative 
Recurrence of 
shocks 
- 100% - - - - 100% 57% 
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